Xtl Biopharma ADR (XTLB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2020 | 06-2020 | 03-2020 | 12-2019 | 09-2019 | |
| Operating Expenses | 0 | 217 | 257 | 0 | 0 |
| Operating Income | N/A | -217 | -257 | N/A | N/A |
| Interest Expense | 0 | 4 | -7 | 0 | 0 |
| Other Income | 0 | -884 | 423 | 0 | 0 |
| Pre-tax Income | 0 | -1,105 | 173 | 0 | 0 |
| Net Income Continuous | N/A | -1,105 | 173 | N/A | N/A |
| Net Income | $N/A | $-1,105 | $173 | $N/A | $N/A |
| EPS Basic Total Ops | N/A | -0.86 | 0.00 | N/A | N/A |
| EPS Basic Continuous Ops | N/A | -0.86 | 0.13 | N/A | N/A |
| EPS Diluted Total Ops | N/A | -0.86 | 0.00 | N/A | N/A |
| EPS Diluted Continuous Ops | N/A | -0.86 | 0.13 | N/A | N/A |
| EPS Diluted Before Non-Recurring Items | 0.04 | N/A | N/A | -0.30 | -0.24 |
| EBITDA(a) | $N/A | $-217 | $-257 | $N/A | $N/A |